title: Response to ‘Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial’.
authors.forename: J
authors.initials: J
authors.lastname: Krhut
authors.forename: V
authors.initials: V
authors.lastname: Samal
authors.forename: D
authors.initials: D
authors.lastname: Nemec
authors.forename: P
authors.initials: P
authors.lastname: Zvara
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A